107 results
8-K
EX-99.1
FGEN
FibroGen Inc
6 May 24
FibroGen Reports First Quarter 2024 Financial Results
4:05pm
facilities, non-current
Liability related to sale of future revenues, non-current
Other long-term liabilities
Total liabilities
Redeemable non-controlling
8-K
EX-99.1
qgqs3u9ga482a
26 Feb 24
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
8-K
EX-99.1
p6ad026dsrv4r
6 Nov 23
FibroGen Reports Third Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
e61pbg0rhlh
7 Aug 23
FibroGen Reports Second Quarter 2023 Financial Results
4:06pm
DEFA14A
aad0s4jn8 pu
31 May 23
Additional proxy soliciting materials
9:00am
8-K
EX-99.1
2reo puau
18 May 23
FibroGen Announces Positive Topline Results from China Pivotal Phase 3 Clinical Trial of Roxadustat for the Treatment of Chemotherapy Induced Anemia
7:35am
8-K
EX-99.1
n62 24h0n
8 May 23
FibroGen Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
1st2nen iufm
7 Nov 22
FibroGen Reports Third Quarter 2022 Financial Results
4:06pm
S-3ASR
EX-1.2
xggil0z
8 Aug 22
Automatic shelf registration
5:12pm